. 2023 May 2;22:145. doi: 10.1186/s12936-023-04575-6

Table 2.

| IPTi coverage in study areas

	Only one dose	Only two doses	Three doses
A. Doses received, irrespective of EPI timepoint*
Received (n/N)	73/707	197/707	368/707
Weighted Proportion (95% CI)	10.42% (7.88–13.65)	27.97% (23.84–32.50)	50.57% (45.38–55.75)

Only one dose

Only two doses

Three doses

A. Doses received, irrespective of EPI timepoint*

Received (n/N)

73/707

197/707

368/707

Weighted Proportion

(95% CI)

10.42% (7.88–13.65)

27.97% (23.84–32.50)

50.57% (45.38–55.75)

	One or more doses	Two or more doses	Three doses
B. Cumulative doses received, irrespective of EPI timepoint
Received (n/N)	638/707	565/707	368/707
Weighted Proportion (95% CI)	88.96% (85.54–91.65)	78.54% (74.30–82.25)	50.57% (45.38–55.75)

	IPTi1 (10 weeks)	IPTi2 (14 weeks)	IPTi3 (9 months)
C. Doses received at each EPI contact
Received (n/N)	574/707	577/707	420/707
Weighted Proportion (95% CI)	80.26% (75.30–84.44)	80.09% (76.30–83.40)	57.72% (53.20–62.11)

Source of information for Sections A and B: 75.68% child’s vaccination card or related document; 24.32% reported by caretaker; for Section C: IPTi1 (10 w) 74.58% child’s vaccination card or related document, 25.42% reported by caretaker; IPTi2 (14 w) 76.26% child’s vaccination card or related document, 23.74% reported by caretaker; IPTi3 (9 m) 75.86% child’s vaccination card or related document, 24.14% reported by caretaker

Penta2 (N = 6), OPV2 (N = 6), Pneumo3 (N = 6), Rota2 (N = 6), Penta3 (N = 6), OPV3 (N = 6), Pneumo3 (N = 6), IPV (N = 6), Yellow fever vaccine (N = 6), MCV1 (N = 6)